29
scIentIfIc ProGraMMe
friday, 17 october 2014
s-51
symposium
17:00–18:30
room leonardo
Dialectical behavior therapy (Dbt): Dissemination and
implementation update
Chairpersons: Anthony Dubose, Seattle, USA
Andre Ivanoff, Seattle, USA
oo1
the scope of Dbt dissemination: Implications of imple-
mentation science
Anthony Dubose, Seattle, USA
oo2
Dbt intensive training: updated us data to date
Andre Ivanoff, Seattle, USA
oo3
Dbt in the uK: updated dissemination and implementation
data
Michaela Swales, Bangor, Wales, United Kingdom
oo4
experimental and innovative Dbt implementations
Marsha Linehan, Seattle, USA
s-52
symposium
17:00–18:30
room borghese
borderline personality disorder – insights in its neuro-
pharmacology and immunology
Chairpersons: Petra Ludaescher, Mannheim, Germany
Dagmar Koethe, Heidelberg, Germany
oo1
neuropeptides and bDnf and emotion dysregulation in
borderline personality disorder
Mercedes Perez-Rodriguez, New York, USA
oo2
the role of opioids in the neurobiology of altered emotion
regulation in borderline personality disorder
Petra Ludaescher, Mannheim, Germany
oo3
neuro-immune interactions in borderline personality
disorder: relationships between Il-18 and sadness induced
brain regional endogenous opioid receptor activation
Alan Prossin, Ann Arbor, USA
oo4
endocannabinoids and neuropeptides in csf and serum
from borderline personality disorder patients
Dagmar Koethe, Heidelberg, Germany
4
th
International congress on borderline
Personality Disorder and allied Disorders
8 – 10 september 2016
university of Vienna // Vienna, austria
European Society for the Study
of Personality Disorders
SAVE
THE
DATE
